Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Non-angiogenic functions of VEGF in breast cancer.

Mercurio AM, Lipscomb EA, Bachelder RE.

J Mammary Gland Biol Neoplasia. 2005 Oct;10(4):283-90. Review.

PMID:
16924371
2.

Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.

Weigand M, Hantel P, Kreienberg R, Waltenberger J.

Angiogenesis. 2005;8(3):197-204. Epub 2005 Nov 19.

PMID:
16328160
3.

Vascular endothelial growth factor expression promotes the growth of breast cancer brain metastases in nude mice.

Kim LS, Huang S, Lu W, Lev DC, Price JE.

Clin Exp Metastasis. 2004;21(2):107-18.

PMID:
15168728
4.

Autocrine signaling in carcinoma: VEGF and the alpha6beta4 integrin.

Mercurio AM, Bachelder RE, Bates RC, Chung J.

Semin Cancer Biol. 2004 Apr;14(2):115-22. Review.

PMID:
15018895
5.

Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.

Bachelder RE, Crago A, Chung J, Wendt MA, Shaw LM, Robinson G, Mercurio AM.

Cancer Res. 2001 Aug 1;61(15):5736-40.

6.

Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF).

Byrne AM, Bouchier-Hayes DJ, Harmey JH.

J Cell Mol Med. 2005 Oct-Dec;9(4):777-94. Review.

7.

Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.

Applanat MP, Buteau-Lozano H, Herve MA, Corpet A.

Adv Exp Med Biol. 2008;617:437-44. doi: 10.1007/978-0-387-69080-3_42.

PMID:
18497067
8.

Sex-steroid regulation of vascular endothelial growth factor in breast cancer.

Hyder SM.

Endocr Relat Cancer. 2006 Sep;13(3):667-87. Review.

9.

Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast.

Safwat MD, Habib F, Elayat A, Oweiss N, Reffat S, Algaidi S.

Folia Morphol (Warsz). 2009 Aug;68(3):144-55.

PMID:
19722158
10.

Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.

Timoshenko AV, Rastogi S, Lala PK.

Br J Cancer. 2007 Oct 22;97(8):1090-8. Epub 2007 Oct 2.

11.

A putative role for psoriasin in breast tumor progression.

Krop I, März A, Carlsson H, Li X, Bloushtain-Qimron N, Hu M, Gelman R, Sabel MS, Schnitt S, Ramaswamy S, Kleer CG, Enerbäck C, Polyak K.

Cancer Res. 2005 Dec 15;65(24):11326-34.

12.

Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis.

Li Y, Ye X, Tan C, Hongo JA, Zha J, Liu J, Kallop D, Ludlam MJ, Pei L.

Oncogene. 2009 Oct 1;28(39):3442-55. doi: 10.1038/onc.2009.212. Epub 2009 Jul 27.

PMID:
19633687
13.

Constitutive and inducible expression and regulation of vascular endothelial growth factor.

Xie K, Wei D, Shi Q, Huang S.

Cytokine Growth Factor Rev. 2004 Oct;15(5):297-324. Review.

PMID:
15450248
14.

A potential role for vascular endothelial growth factor-D as an autocrine growth factor for human breast carcinoma cells.

Akahane M, Akahane T, Shah A, Okajima E, Thorgeirsson UP.

Anticancer Res. 2005 Mar-Apr;25(2A):701-7.

15.

Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.

Palmieri D, Astigiano S, Barbieri O, Ferrari N, Marchisio S, Ulivi V, Volta C, Manduca P.

Exp Cell Res. 2008 Jul 1;314(11-12):2289-98. doi: 10.1016/j.yexcr.2008.04.016. Epub 2008 May 10.

PMID:
18570923
17.

Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.

Affara NI, Robertson FM.

In Vivo. 2004 Sep-Oct;18(5):525-42. Review.

18.

Lentivirus-mediated small interfering RNA targeting VEGF-C inhibited tumor lymphangiogenesis and growth in breast carcinoma.

Guo B, Zhang Y, Luo G, Li L, Zhang J.

Anat Rec (Hoboken). 2009 May;292(5):633-9. doi: 10.1002/ar.20893.

19.

Control of VEGF expression in triple-negative breast carcinoma cells by suppression of SAF-1 transcription factor activity.

Ray A, Dhar S, Ray BK.

Mol Cancer Res. 2011 Aug;9(8):1030-41. doi: 10.1158/1541-7786.MCR-10-0598. Epub 2011 Jun 10.

20.

Breast cancer cell-derived fibroblast growth factor 2 and vascular endothelial growth factor are chemoattractants for bone marrow stromal stem cells.

Ritter E, Perry A, Yu J, Wang T, Tang L, Bieberich E.

Ann Surg. 2008 Feb;247(2):310-4. doi: 10.1097/SLA.0b013e31816401d5.

PMID:
18216538
Items per page

Supplemental Content

Write to the Help Desk